Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126257661 | 12625766 | 1 | I | 201604 | 20140604 | 20160805 | 20160805 | EXP | US-PFIZER INC-2014154666 | PFIZER | 52.00 | YR | M | Y | 0.00000 | 20160805 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126257661 | 12625766 | 1 | PS | RAPAMUNE | SIROLIMUS | 1 | Oral | 2 MG, DAILY | 21110 | 2 | MG | TABLET | |||||||
126257661 | 12625766 | 2 | SS | RAPAMUNE | SIROLIMUS | 1 | 21110 | TABLET | |||||||||||
126257661 | 12625766 | 3 | SS | MYFORTIC | MYCOPHENOLATE SODIUM | 1 | UNK | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126257661 | 12625766 | 1 | Anxiety |
126257661 | 12625766 | 2 | Prophylaxis against transplant rejection |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126257661 | 12625766 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126257661 | 12625766 | Fall | |
126257661 | 12625766 | Femur fracture | |
126257661 | 12625766 | Headache | |
126257661 | 12625766 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |